MP Ted Falk Credits Local Activists as Cystic Fibrosis Medication Becomes Accessible in Manitoba

Steinbach, MB – MP Ted Falk is praising the efforts of local activists as a transformative cystic fibrosis (CF) medication was added to the provincial drug program formulary.

Last week, the Government of Manitoba announced it was adding Trikafta to its drug formulary, qualifying the medication for coverage for those who meet the province’s eligibility criteria. This comes after Health Canada approved the drug for sale in Canada in June.

“This is great news for those living with cystic fibrosis,” said Falk. “Access to Trikafta could mean the difference between life and death for many suffering from CF.”

Trikafta, a new triple-combination cystic fibrosis drug, is used to both treat the symptoms of CF and to target the basic defect from specific genetic mutations that cause CF.

Falk says it was local activists who first alerted him to the drug’s existence and asked him to help ensure the medication would quickly be made available in Canada.

“A handful of local residents reached out to me, sat down with me, and helped me understand the critical need for access to Trikafta in Canada,” said Falk. “Their efforts were part of a national awareness campaign, so as I began working with other MPs on this issue it was already on peoples’ radar.”

In May 2020, fifty-nine Conservative MPs sent an open letter to federal Health Minister Patty Hajdu urging Health Canada to approve the drug for distribution in Canada. Parliamentarians also came together across party lines to press for action, such as through the All Party Emergency Access to Trikafta Caucus.

“Once Trikafta was approved by Health Canada, provincial governments had to take it from there,” noted Falk. “I’m thankful for the Government of Manitoba’s swift response.”

“Many Canadians suffer from CF, including several Provencher residents,” said Falk. “For those waiting for access, I know this has been a long time in coming. Thank you for your tireless dedication to seeing this through. This achievement will make a world of difference in the lives of those with CF!”